TKT and neoplasm: Immunohistochemistry with Ki67 antibody showed that AAV8-TR2-OriP-TK with GCV strongly inhibited iSLK cell growth and the overall number of KSHV-infected live cells (EGFP positive) in the tumor mass is also lower (Figure 7F).